The peak was wrong.
Within four hours, the system went live. Ananya uploaded the “Drug Alert” onto the IPC’s website, flagging the specific batch number. This wasn't a suggestion. Under the Drugs and Cosmetics Act, this alert forced every state drug controller from Kerala to Kashmir to seize that batch from every pharmacy shelf. ipksindia
The fluorescent lights of the IPC Reference Lab in Ghaziabad hummed a low, steady note. Dr. Ananya Sharma stared at the High-Performance Liquid Chromatography (HPLC) readout, and her blood ran cold. The peak was wrong
She was testing a batch of a common antimalarial drug, Artesunate, sent from a manufacturer in Nagpur. The label claimed it contained 500 mg of active ingredient. The machine said 120 mg. The rest was cheap fillers—chalk, starch, and a nasty binder that could cause kidney failure. This wasn't a suggestion
“You see, Mr. Mehta?” she said quietly. “The Indian Pharmacopoeia isn't just a book you put on a shelf to impress the regulators. It is a contract with the patient. You signed it when you printed ‘IP’ on your label.”
“No,” Ananya said. “It won't. Because this time, we have the data, we have the IP standard, and we have the law. Seal the unit.”